The table below shows Syndax Pharmaceuticals Inc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$172.35M
$23.68M
$0.00
$0.00
$139.71M
$1.52M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$258.78M
$241.65M
$163.03M
$118.50M
$88.25M
$50.44M
SG&A
$179.68M
SNDX annual revenue (10-K history)
Syndax Pharmaceuticals Inc reported annual revenue of $172.35M for fiscal year 2025. That is up 627.8% from $23.68M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.22M (FY 2016) to $172.35M. Figures come from the company's audited annual reports as filed with the SEC.